10 news items
Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
CELU
19 Apr 24
of future events and views as of the date of this communication. Subsequent events and developments could cause assessments to change. Accordingly, forward
Celularity Abstract "Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials" Accepted at ORS Tendon Conference 2024
CELU
18 Apr 24
expectations, plans, or forecasts of future events and views as of the date of this communication. Subsequent events and developments could cause assessments
Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial Products
CELU
15 Apr 24
, or forecasts of future events and views as of the date of this communication. Subsequent events and developments could cause assessments to change. Accordingly
Celularity to Present Data Showing Senescent Cell Elimination by Off-the-Shelf Natural Killer Cells Derived from Human Placental Cells
CELU
8 Apr 24
events and views as of the date of this communication. Subsequent events and developments could cause assessments to change. Accordingly, forward
Celularity Receives Healthcare Common Procedure Coding System Q Code Approval From The U.S. Centers For Medicare & Medicaid Services For Biovance 3L
CELU
26 Mar 24
. Robert J. Hariri, M.D., Ph.D., Celularity CEO, chairman and founder. "The medical community has been rapidly adopting this product, and the HCPCS Q
oqacnf uf
CELU
20 Mar 24
as of the date of this communication. Subsequent events and developments could cause assessments to change. Accordingly, forward-looking statements
zigyldguq0b jv5tvzly149jfm8aqvuzz2gt
CELU
14 Mar 24
current expectations, plans, or forecasts of future events and views as of the date of this communication. Subsequent events and developments could
ge9mharn7i3rjbgsrmd8abst6i2w16q3dsmkgsvbbe3
CELU
12 Mar 24
decline. As the SBMT and World Brain Mapping Foundation (WBMF) are helping to drive collaboration between the academic and industrial communities
xiqdvwbron f3rgk
CELU
DPZ
PPC
26 Feb 24
% to $305.74 in the after-hours trading session.
Analysts expect Zoom Video Communications, Inc
0vkn3
CELU
23 Feb 24
community of investors." The 1-for-10 reverse stock split will automatically convert 10 current shares of Celularity's Class A common stock
- Prev
- 1
- Next